Toxocara Seroprevalence in Europe and Considerations for Future Research
Abstract
1. Introduction
2. Materials and Methods
3. Results and Discussion
4. Toxocarosis Diagnosis Methods: Future Directions
Possible Diagnostic Methods of Toxocara Infections
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Hamilton, C.M.; Yoshida, A.; Pinelli, E.; Holland, C.V. Toxocariasis. In Helminth Infections and Their Impact on Global Public Health; Bruschi, F., Ed.; Springer: Vienna, Austria, 2014; pp. 425–460. ISBN 978-3-7091-1782-8. [Google Scholar]
 - Magnaval, J.F.; Glickman, L.T.; Dorchies, P.; Morassin, B. Highlights of Human Toxocariasis. Korean J. Parasitol. 2001, 39, 1–11. [Google Scholar] [CrossRef]
 - Glickman, L.T.; Schantz, P.M. Epidemiology and Pathogenesis of Zoonotic Toxocariasis. Epidemiol. Rev. 1981, 3, 230–250. [Google Scholar] [CrossRef]
 - Rostami, A.; Ma, G.; Wang, T.; Koehler, A.V.; Hofmann, A.; Chang, B.C.H.; Macpherson, C.N.; Gasser, R.B. Human Toxocariasis–A Look at a Neglected Disease through an Epidemiological ‘Prism’. Infect. Genet. Evol. 2019, 74, 104002. [Google Scholar] [CrossRef]
 - Strube, C.; Heuer, L.; Janecek, E. Toxocara spp. Infections in Paratenic Hosts. Vet. Parasitol. 2013, 193, 375–389. [Google Scholar] [CrossRef]
 - Despommier, D. Toxocariasis: Clinical Aspects, Epidemiology, Medical Ecology, and Molecular Aspects. Clin. Microbiol. Rev. 2003, 16, 265–272. [Google Scholar] [CrossRef] [PubMed]
 - Ma, G.; Holland, C.V.; Wang, T.; Hofmann, A.; Fan, C.-K.; Maizels, R.M.; Hotez, P.J.; Gasser, R.B. Human Toxocariasis. Lancet Infect. Dis. 2018, 18, e14–e24. [Google Scholar] [CrossRef] [PubMed]
 - Fialho, P.M.M.; Corrêa, C.R.S. A Systematic Review of Toxocariasis: A Neglected but High-Prevalence Disease in Brazil. Am. J. Trop. Med. Hyg. 2016, 94, 1193–1199. [Google Scholar] [CrossRef]
 - Raissi, V.; Masoumi, M.T.; Ibrahim, A.; Etemadi, S.; Getso, M.; Jalali, P.; Babaei Pouya, N.; Zareie, M.; Ehsani Amraei, F.; Raiesi, O. Spatial Analysis of Toxocara spp. Eggs in Soil as a Potential for Serious Human Infection. Comp. Immunol. Microbiol. Infect. Dis. 2021, 75, 101619. [Google Scholar] [CrossRef]
 - Cooper, P.J. Toxocara Canis Infection: An Important and Neglected Environmental Risk Factor for Asthma? Clin. Exp. Allergy 2008, 38, 551–553. [Google Scholar] [CrossRef]
 - Moreira, G.M.S.G.; Telmo, P.d.L.; Mendonça, M.; Moreira, Â.N.; McBride, A.J.A.; Scaini, C.J.; Conceição, F.R. Human Toxocariasis: Current Advances in Diagnostics, Treatment, and Interventions. Trends Parasitol. 2014, 30, 456–464. [Google Scholar] [CrossRef] [PubMed]
 - Chieffi, P.P.; Zevallos Lescano, S.A.; Rodrigues e Fonseca, G.; Santos, S.V. dos Human Toxocariasis: 2010 to 2020 Contributions from Brazilian Researchers. Res. Rep. Trop. Med. 2021, 12, 81–91. [Google Scholar] [CrossRef]
 - Smith, H.; Noordin, R. Diagnostic Limitations and Future Trends in the Serodiagnosis of Human Toxocariasis. Toxocara Enigm. Parasite 2006, 89–112. [Google Scholar]
 - Meyers, W.M.; Neafie, R.C.; Marty, A.M.; Wear, D.J. Toxocariasis. In Pathology of Infectious Diseases, Volume 1: Helminthiases; Armed Forces Institute of Pathology, American Registry of Pathology: Washington, DC, USA, 2000; pp. 411–421. ISBN 1-881041-65-4. [Google Scholar]
 - Manini, M.P.; Marchioro, A.A.; Colli, C.M.; Nishi, L.; Falavigna-Guilherme, A.L. Association between Contamination of Public Squares and Seropositivity for Toxocara spp. in Children. Vet. Parasitol. 2012, 188, 48–52. [Google Scholar] [CrossRef] [PubMed]
 - Souza, R.F.; Dattoli, V.C.C.; Mendonça, L.R.; de Jesus, J.R.; Baqueiro, T.; de Carvalho Santana, C.; Santos, N.M.; Barrouin-Melo, S.M.; Alcantara-Neves, N.M. Prevalence and Risk Factors of Human Infection by Toxocara Canis in Salvador, State of Bahia, Brazil. Rev. Da Soc. Bras. De Med. Trop. 2011, 44, 516–519. [Google Scholar] [CrossRef]
 - Mendonça, L.R.; Figueiredo, C.A.; Esquivel, R.; Fiaccone, R.L.; Pontes-de-Carvalho, L.; Cooper, P.; Barreto, M.L.; Alcantara-Neves, N.M. Seroprevalence and Risk Factors for Toxocara Infection in Children from an Urban Large Setting in Northeast Brazil. Acta Trop. 2013, 128, 90–95. [Google Scholar] [CrossRef] [PubMed]
 - Bakhshani, A.; Maleki, M.; Haghparast, A.; Parande Shirvan, S.; Borji, H. A Survey on Toxocara Cati Eggs on the Hair of Stray Cats: A Potential Risk Factor for Human Toxocariasis in Northeastern Iran. Comp. Immunol. Microbiol. Infect. Dis. 2019, 64, 10–13. [Google Scholar] [CrossRef] [PubMed]
 - Öge, H.; Öge, S.; Özbakış, G.; Gürcan, S. Comparison of Toxocara Eggs in Hair and Faecal Samples from Owned Dogs and Cats Collected in Ankara, Turkey. Vet. Parasitol. 2014, 206, 227–231. [Google Scholar] [CrossRef]
 - Rostami, A.; Sepidarkish, M.; Ma, G.; Wang, T.; Ebrahimi, M.; Fakhri, Y.; Mirjalali, H.; Hofmann, A.; Macpherson, C.N.L.; Hotez, P.J.; et al. Global Prevalence of Toxocara Infection in Cats. In Advances in Parasitology; Elsevier: Amsterdam, The Netherlands, 2020; Volume 109, pp. 615–639. ISBN 978-0-12-820958-5. [Google Scholar]
 - Chieffi, P.P.; dos Santos, S.V.; de Queiroz, M.L.; Lescano, S.A.Z. Human Toxocariasis: Contribution by Brazilian Researchers. Rev. Inst. Med. Trop. São Paulo 2009, 51, 301–308. [Google Scholar] [CrossRef]
 - Fava, N.M.N.; Cury, M.C.; Santos, H.A.; Takeuchi-Storm, N.; Strube, C.; Zhu, X.-Q.; Taira, K.; Odoevskaya, I.; Panovag, O.; Mateus, T.L.; et al. Phylogenetic Relationships among Toxocara spp. and Toxascaris sp. from Different Regions of the World. Vet. Parasitol. 2020, 282, 109133. [Google Scholar] [CrossRef]
 - Zhan, B.; Ajmera, R.; Geiger, S.M.; Gonçalves, M.T.P.; Liu, Z.; Wei, J.; Wilkins, P.P.; Fujiwara, R.; Gazzinelli-Guimaraes, P.H.; Bottazzi, M.E. Identification of Immunodominant Antigens for the Laboratory Diagnosis of Toxocariasis. Trop. Med. Int. Health 2015, 20, 1787–1796. [Google Scholar] [CrossRef]
 - Rubinsky-Elefant, G.; Hoshino-Shimizu, S.; Jacob, C.M.A.; Sanchez, M.C.A.; Ferreira, A.W. Potential Immunological Markers for Diagnosis and Therapeutic Assessment of Toxocariasis. Rev. Inst. Med. Trop. São Paulo 2011, 53, 61–65. [Google Scholar] [CrossRef]
 - Magnaval, J.-F.; Bouhsira, E.; Fillaux, J. Therapy and Prevention for Human Toxocariasis. Microorganisms 2022, 10, 241. [Google Scholar] [CrossRef]
 - Kanecki, K.; Lewtak, K.; Szot, P.; Goryński, P.; Kosińska, I.; Kanecka, A.; Nitsch-Osuch, A. Visceral Larva Migrans among Hospitalized Patients in Poland: Analysis of National Hospital Discharge Data from 2014 to 2023. Sci. Rep. 2025, 15, 34752. [Google Scholar] [CrossRef] [PubMed]
 - Fiľakovská Bobáková, D.; Kalinova, Z.; Hatalová, E.; Halanova, M. Toxocariasis, Risk and Protective Factors, and Mental Health Difficulties in Early Childhood: A Comparison of Marginalised Roma Communities and the Majority Population. Parasitol. Res. 2025, 124, 106. [Google Scholar] [CrossRef]
 - Ardelean, A.A.; Lighezan, R.; Ursoniu, S.; Sprintar, S.A.; Oatis, D.A.; Mihu, A.G.; Lupu, M.A.; Olariu, T.R. First Report on the Seroprevalence and Risk Factors Associated with Toxocara Infection in Blood Donors from Romania. Pathogens 2025, 14, 857. [Google Scholar] [CrossRef]
 - Healy, S.; Morgan, E.; Betson, M.; Prada, J.M. Modelling the Risk of Food-Borne Transmission of Toxocara spp. to Humans. Epidemiol. Infect. 2025, 153, e69. [Google Scholar] [CrossRef]
 - Reis, J.; Carmo, F.; Miranda, J.; Seixas, A.P.; Mota, M. Eosinophilia and IgE Elevation: An Uncommon Toxocara Infection. Cureus 2025, 17, e77965. [Google Scholar] [CrossRef] [PubMed]
 - Healy, S.R.; Morgan, E.R.; Prada, J.M.; Karadjian, G.; Chevillot, A.; Betson, M. First Use of Tissue Exudate Serology to Identify Toxocara spp. Infection in Food Animals. Int. J. Parasitol. 2024, 54, 303–310. [Google Scholar] [CrossRef] [PubMed]
 - Bustamante, J.; Sainz, T.; Pérez, S.; Rodríguez-Molino, P.; Montero Vega, D.; Mellado, M.J.; García López-Hortelano, M. Toxocariasis in Migrant Children: A 6 Years’ Experience in a Reference Pediatric Unit in Spain. Travel Med. Infect. Dis. 2022, 47, 102288. [Google Scholar] [CrossRef]
 - Balacheff, Q.; Lovato, J.-B.; Coiffard, B.; L’Ollivier, C.; Cassir, N.; Reynaud-Gaubert, M. Splenic Abscess Caused by Toxocara spp. in a Lung Transplant Recipient, Marseille, France. Transpl. Infect. Dis. 2021, 23, e13651. [Google Scholar] [CrossRef]
 - Fecková, M.; Antolová, D.; Zaleśny, G.; Halánová, M.; Štrkolcová, G.; Goldová, M.; Weissová, T.; Lukáč, B.; Nováková, M. Seroepidemiology of Human Toxocariasis in Selected Population Groups in Slovakia: A Cross-Sectional Study. J. Infect. Public Health 2020, 13, 1107–1111. [Google Scholar] [CrossRef]
 - Kantarakia, C.; Tsoumani, M.E.; Galanos, A.; Mathioudakis, A.G.; Giannoulaki, E.; Beloukas, A.; Voyiatzaki, C. Comparison of the Level of Awareness about the Transmission of Echinococcosis and Toxocariasis between Pet Owners and Non-Pet Owners in Greece. Int. J. Environ. Res. Public Health 2020, 17, 5292. [Google Scholar] [CrossRef]
 - Macejova, Z.; Kristian, P.; Janicko, M.; Halanova, M.; Drazilova, S.; Antolova, D.; Marekova, M.; Pella, D.; Madarasova-Geckova, A.; Jarcuska, P.; et al. The Roma Population Living in Segregated Settlements in Eastern Slovakia Has a Higher Prevalence of Metabolic Syndrome, Kidney Disease, Viral Hepatitis B and E, and Some Parasitic Diseases Compared to the Majority Population. Int. J. Environ. Res. Public Health 2020, 17, 3112. [Google Scholar] [CrossRef]
 - Pennelegion, C.; Drake, J.; Wiseman, S.; Wright, I. Survey of UK Pet Owners Quantifying Internal Parasite Infection Risk and Deworming Recommendation Implications. Parasit. Vectors 2020, 13, 218. [Google Scholar] [CrossRef]
 - Skulinova, K.; Novak, J.; Kasny, M.; Kolarova, L. Seroprevalence of Larval Toxocarosis in the Czech Republic. Acta Parasitol. 2020, 65, 68–76. [Google Scholar] [CrossRef]
 - Magnaval, J.-F.; Fillaux, J.; Cassaing, S.; Valentin, A.; Iriart, X.; Berry, A. Human Toxocariasis and Atopy. Parasite 2020, 27, 32. [Google Scholar] [CrossRef] [PubMed]
 - Strube, C.; Raulf, M.-K.; Springer, A.; Waindok, P.; Auer, H. Seroprevalence of Human Toxocarosis in Europe: A Review and Meta-Analysis. Adv. Parasitol. 2020, 109, 375–418. [Google Scholar] [CrossRef] [PubMed]
 - Nicoletti, A.; García, H.H.; Cicero, C.E.; Portaro, G.; Giuliano, L.; Patti, F.; Sofia, V.; Noh, J.; Handali, S.; Zappia, M. Lack of Evidence for Toxocara Infection in Italian Myelitis Patients. Neurol. Sci. 2020, 41, 239–241. [Google Scholar] [CrossRef]
 - Brydak-Godowska, J.; Moskal, K.; Borkowski, P.K.; Przybyś, M.; Turczyńska, M.; Kęcik, D. A Retrospective Observational Study of Uveitis in a Single Center in Poland with a Review of Findings in Europe. Med. Sci. Monit. 2018, 24, 8734–8749. [Google Scholar] [CrossRef] [PubMed]
 - Peju, M.; Deroux, A.; Pelloux, H.; Bouillet, L.; Epaulard, O. Hypereosinophilia: Biological Investigations and Etiologies in a French Metropolitan University Hospital, and Proposed Approach for Diagnostic Evaluation. PLoS ONE 2018, 13, e0204468. [Google Scholar] [CrossRef]
 - Overbosch, F.W.; van Gool, T.; Matser, A.; Sonder, G.J.B. Low Incidence of Helminth Infections (Schistosomiasis, Strongyloidiasis, Filariasis, Toxocariasis) among Dutch Long-Term Travelers: A Prospective Study, 2008-2011. PLoS ONE 2018, 13, e0197770. [Google Scholar] [CrossRef]
 - Kroten, A.; Toczylowski, K.; Oldak, E.; Sulik, A. Toxocarosis in Children: Poor Hygiene Habits and Contact with Dogs Is Related to Longer Treatment. Parasitol. Res. 2018, 117, 1513–1519. [Google Scholar] [CrossRef]
 - Boldiš, V.; Ondriska, F.; Lipková, S. Assessment of the Diagnostic Value of Specific Anti-Toxocara IgA in Slovakian Patients Suspected to Have Toxocarosis. Folia Microbiol. 2018, 63, 345–351. [Google Scholar] [CrossRef]
 - Jõgi, N.O.; Svanes, C.; Siiak, S.P.; Logan, E.; Holloway, J.W.; Igland, J.; Johannessen, A.; Levin, M.; Real, F.G.; Schlunssen, V.; et al. Zoonotic Helminth Exposure and Risk of Allergic Diseases: A Study of Two Generations in Norway. Clin. Exp. Allergy 2018, 48, 66–77. [Google Scholar] [CrossRef]
 - Posová, H.; Hrušková, Z.; Havrdová, E.; Kolářová, L. Toxocara spp. Seronegativity in Czech Patients with Early Form of Multiple Sclerosis–Clinically Isolated Syndrome. Epidemiol. Mikrobiol. Imunol. 2017, 66, 124–127. [Google Scholar] [PubMed]
 - Martelli, G.; Di Girolamo, C.; Zammarchi, L.; Angheben, A.; Morandi, M.; Tais, S.; Degani, M.; El Hamad, I.; Caligaris, S.; Ciannameo, A.; et al. Seroprevalence of Five Neglected Parasitic Diseases among Immigrants Accessing Five Infectious and Tropical Diseases Units in Italy: A Cross-Sectional Study. Clin. Microbiol. Infect. 2017, 23, 335.e1–335.e5. [Google Scholar] [CrossRef] [PubMed]
 - Gabrielli, S.; Tasić-Otašević, S.; Ignjatović, A.; Fraulo, M.; Trenkić-Božinović, M.; Momčilović, S.; Cancrini, G. Seroprevalence and Risk Factors for Toxocara canis Infection in Serbia During 2015. Foodborne Pathog. Dis. 2017, 14, 43–49. [Google Scholar] [CrossRef] [PubMed]
 - Halsby, K.; Senyonjo, L.; Gupta, S.; Ladbury, G.; Suvari, M.; Chiodini, P.; Morgan, D. Epidemiology of Toxocariasis in England and Wales. Zoonoses Public Health 2016, 63, 529–533. [Google Scholar] [CrossRef]
 - Lassen, B.; Janson, M.; Viltrop, A.; Neare, K.; Hütt, P.; Golovljova, I.; Tummeleht, L.; Jokelainen, P. Serological Evidence of Exposure to Globally Relevant Zoonotic Parasites in the Estonian Population. PLoS ONE 2016, 11, e0164142. [Google Scholar] [CrossRef]
 - Mughini-Gras, L.; Harms, M.; van Pelt, W.; Pinelli, E.; Kortbeek, T. Seroepidemiology of Human Toxocara and Ascaris Infections in the Netherlands. Parasitol. Res. 2016, 115, 3779–3794. [Google Scholar] [CrossRef]
 - Papavasilopoulos, V.; Bonatsos, G.; Elefsiniotis, I.; Birbas, C.; Panagopoulos, P.; Trakakis, E. Seroepidemiological Investigation of Toxocara canis in a Female Greek Pregnant Population in the Area of Athens. Clin. Exp. Obstet. Gynecol. 2016, 43, 384–387. [Google Scholar] [CrossRef]
 - Boldiš, V.; Ondriska, F.; Špitalská, E.; Reiterová, K. Immunodiagnostic Approaches for the Detection of Human Toxocarosis. Exp. Parasitol. 2015, 159, 252–258. [Google Scholar] [CrossRef]
 - Lee, R.M.; Moore, L.B.; Bottazzi, M.E.; Hotez, P.J. Toxocariasis in North America: A Systematic Review. PLoS Neglected Trop. Dis. 2014, 8, e3116. [Google Scholar] [CrossRef]
 - Parise, M.E.; Hotez, P.J.; Slutsker, L. Neglected Parasitic Infections in the United States: Needs and Opportunities. Am. J. Trop. Med. Hyg. 2014, 90, 783–785. [Google Scholar] [CrossRef] [PubMed]
 - Woodhall, D.M.; Eberhard, M.L.; Parise, M.E. Neglected Parasitic Infections in the United States: Toxocariasis. Am. J. Trop. Med. Hyg. 2014, 90, 810–813. [Google Scholar] [CrossRef]
 - Bellanger, A.-P.; Humbert, P.; Gavignet, B.; Deschaseaux, A.D.; Barisien, C.; Roussel, S.; Millon, L.; Aubin, F.; Piarroux, R. Comparative Assessment of Enzyme-Linked Immunosorbent Assay and Western Blot for the Diagnosis of Toxocariasis in Patients with Skin Disorders. Br. J. Dermatol. 2010, 162, 80–82. [Google Scholar] [CrossRef]
 - Wilkins, P.P. Immunodiagnosis of Human Toxocariasis and Prospects for Improved Diagnostics. Curr. Trop. Med. Rep. 2014, 1, 44–51. [Google Scholar] [CrossRef]
 - Noordin, R.; Yunus, M.H.; Tan Farrizam, S.N.; Arifin, N. Chapter Seven–Serodiagnostic Methods for Diagnosing Larval Toxocariasis. In Advances in Parasitology; Bowman, D.D., Ed.; Toxocara and Toxocariasis; Academic Press: Cambridge, MA, USA, 2020; Volume 109, pp. 131–152. [Google Scholar]
 - Chen, J.; Liu, Q.; Liu, G.-H.; Zheng, W.-B.; Hong, S.-J.; Sugiyama, H.; Zhu, X.-Q.; Elsheikha, H.M. Toxocariasis: A Silent Threat with a Progressive Public Health Impact. Infect. Dis. Poverty 2018, 7, 59. [Google Scholar] [CrossRef]
 - Baharudeen, Z.; Noordin, R.; Soon, L.T.; Balachandra, D.; Anuar, N.S.; Mustafa, F.H.; Rahumatullah, A. Isolation and Production of Human Monoclonal Antibody Proteins against a Toxocara Canis Excretory-Secretory Recombinant Antigen. Pathogens 2022, 11, 1232. [Google Scholar] [CrossRef] [PubMed]
 - Trashin, S.; Morales-Yánez, F.; Thiruvottriyur Shanmugam, S.; Paredis, L.; Carrión, E.N.; Sariego, I.; Muyldermans, S.; Polman, K.; Gorun, S.M.; De Wael, K. Nanobody-Based Immunosensor Detection Enhanced by Photocatalytic-Electrochemical Redox Cycling. Anal. Chem. 2021, 93, 13606–13614. [Google Scholar] [CrossRef] [PubMed]
 - Morales-Yánez, F.; Trashin, S.; Sariego, I.; Roucher, C.; Paredis, L.; Chico, M.; De Wael, K.; Muyldermans, S.; Cooper, P.; Polman, K. Electrochemical Detection of Toxocara Canis Excretory-Secretory Antigens in Children from Rural Communities in Esmeraldas Province, Ecuador: Association between Active Infection and High Eosinophilia. Parasit. Vectors 2020, 13, 245. [Google Scholar] [CrossRef]
 - Morales-Yánez, F.; Trashin, S.; Hermy, M.; Sariego, I.; Polman, K.; Muyldermans, S.; De Wael, K. Fast One-Step Ultrasensitive Detection of Toxocara Canis Antigens by a Nanobody-Based Electrochemical Magnetosensor. Anal. Chem. 2019, 91, 11582–11588. [Google Scholar] [CrossRef]
 - Zibaei, M.; Rokni, M.B.; Sohrabi, N.; Sepahvand, A.; Raiesi, O.; Getso, M.I.; Alizadeh, G.; Ibrahim, A.; Yarahmadi, M.; Raissi, V. Changes in the Expression of miR-103a and miR-21: A Functional Diagnosis of Toxocariasis in Rats. J. Med. Microbiol. 2022, 71, 001532. [Google Scholar] [CrossRef]
 - Avila, H.G.; Risso, M.G.; Ruybal, P.; Repetto, S.A.; Butti, M.J.; Trangoni, M.D.; Grune Löffler, S.; Pérez, V.M.; Periago, M.V. Development of a Low-Cost Copro-LAMP Assay for Simultaneous Copro-Detection of Toxocara Canis and Toxocara Cati. Parasitology 2021, 148, 819–826. [Google Scholar] [CrossRef] [PubMed]
 - Azimian, H.; Shokrani, H.; Fallahi, S. Molecular Evaluation of Toxocara Species in Stray Cats Using Loop-Mediated Isothermal Amplification (Lamp) Technique as a Rapid, Sensitive and Simple Screening Assay. Vet. Med. Sci. 2021, 7, 647–653. [Google Scholar] [CrossRef]
 - de Moura, M.Q.; Terto, W.D.d.S.; Avila, L.F.d.C.; Campos, V.F.; Domingues, W.B.; Pinheiro, N.B.; Capella, G.d.A.; Strothmann, A.L.; Scaini, C.J.; Berne, M.E.A. Quantification of Toxocara Canis DNA by qPCR in Mice Inoculated with Different Infective Doses. Parasitol. Int. 2020, 78, 102134. [Google Scholar] [CrossRef]
 - Özbakış, G.; Doğanay, A. Visceral Larva Migrans Detection Using PCR-RFLP in BALB/c Mice Infected with Toxocara Canis. J. Helminthol. 2019, 94, e70. [Google Scholar] [CrossRef]
 - Raulf, M.-K.; Jordan, D.; Auer, H.; Warnecke, J.M.; Lepenies, B.; Strube, C. A New ELISA and Western Blot Technique Based on Recombinant TES Antigen and/or Larval Antigen for the Detection of Toxocariasis in Humans. Parasitology 2021, 148, 333–340. [Google Scholar] [CrossRef] [PubMed]
 - Morales-Yanez, F.J.; Sariego, I.; Vincke, C.; Hassanzadeh-Ghassabeh, G.; Polman, K.; Muyldermans, S. An Innovative Approach in the Detection of Toxocara canis Excretory/Secretory Antigens Using Specific Nanobodies. Int. J. Parasitol. 2019, 49, 635–645. [Google Scholar] [CrossRef] [PubMed]
 - Mesa-Arango, J.A.; Olave-Velandia, A.M.; García-Montoya, G.M.; Isaza-Agudelo, J.P.; Jiménez-Ruiz, A.; Alzate, J.F. Evaluation of New Toxocara Canis Chimeric Antigens as an Alternative to Conventional TES-Ag for Anti-Toxocara Antibodies Detection. Heliyon 2022, 8, e11144. [Google Scholar] [CrossRef]
 - Dziemian, E.; Żarnowska, H.; Kołodziej-Sobocińska, M.; Machnicka, B. Determination of the Relative Avidity of the Specific IgG Antibodies in Human Toxocariasis. Parasite Immunol. 2008, 30, 187–190. [Google Scholar] [CrossRef] [PubMed]
 - Rudzińska, M.; Kowalewska, B.; Sikorska, K. Clinical Usefulness of Western Blotting and ELISA Avidity for the Diagnosis of Human Toxocariasis. Parasite Immunol. 2017, 39, e12400. [Google Scholar] [CrossRef]
 - Ricciardi, A.; Ndao, M. Diagnosis of Parasitic Infections: What’s Going On? SLAS Discov. 2015, 20, 6–21. [Google Scholar] [CrossRef] [PubMed]
 - Huang, L.; Sun, L.; Liu, C.; Li, S.; Zhang, T.; Luo, X.; Ding, X. Diagnosis of Ocular Toxocariasis by Serum and Aqueous Humor IgG ELISA. Transl. Vis. Sci. Technol. 2021, 10, 33. [Google Scholar] [CrossRef] [PubMed]
 
| No. | Author, Year, Country, Reference  | Sample Type and Size | Assay | Toxocarosis Prevalence/Related Data | Clinical Utility | 
|---|---|---|---|---|---|
| 1 | Kanecki K, 2025, Poland, [26]  | ICD-10 code diagnoses in a nationwide database  3559 patients—1888 males (53%) and 1671 females (47%)  | Surveying the database for diagnosis of visceral larva migrans (VLM, toxocarosis; ICD-10 code B83.0). | The mean VLM hospitalisation rate was estimated at 0.93 per 100,000 admissions. | This retrospective study reported data that may be useful for comparative analyses in global contexts. The authors underlined the importance of higher public health standards for the monitoring and prevention of VLM. | 
| 2 | Fiľakovská Bobáková D et al., 2025, Slovakia, [27]  | 88 blood samples from children  49 children from the Slovak majority population and 39 from marginalised Roma communities (MRCs)  | Anti-T. canis IgG antibodies were detected in serum samples using ELISA. | The children belonging to the majority population had a seropositivity rate of 20.4%, while children from MRCs had a higher detected prevalence of 35.9%. | This comparative study found a higher prevalence of toxocarosis in MRCs, and Toxocara seropositivity was associated with higher levels of early mental health difficulties.  Integrated public health interventions for parasitic infections are especially necessary in susceptible populations.  | 
| 3 | Ardelean AA et al., 2025,  Romania, [28]  | Serum samples from 1347 Romanian blood donors | Anti-Toxocara canis IgG antibodies were detected in serum samples with an ELISA IgG kit (Euroimmun, Germany, Berlin), using the EUROIMMUN Analyzer I-2P. | Anti-Toxocara antibodies were detected in 29.6% of samples. A higher seroprevalence was observed in donors from rural areas compared to urban areas and in male donors compared to females.  | The authors used a multivariate logistic regression model, which indicated that the main factors associated with a higher Toxocara seroprevalence were a lower level of education, younger age, male gender, consumption of undercooked or raw poultry, and contact with soil.  Toxocara infection prevalence in this region was considered significant, underlining the necessity of health education programs that focus on public awareness and promote preventive behaviours in populations with the identified risk factors.  | 
| 4 | Healy S et al., 2025,  UK, [29]  | 1000 computer modelled samples of spinach and meat | The models were based on previous field data for spinach estimated egg load by qPCR and meat seroprevalence data for larval load estimated by ELISA. The mathematical models were created in a Bayesian framework.  | The average human risk of Toxocara spp. infection per portion of spinach consumed was estimated as 0.016%, and for undercooked meat, the estimated risk was 0.172% per portion. | The models estimated a low risk of infection with Toxocara spp. by consuming these foods, although with a 10-fold higher infection risk in the case of consuming undercooked meat compared to spinach. | 
| 5 | Reis J et al., 2025, Portugal [30]  | A clinical report of a 56-year-old woman, with persistent significant eosinophilia and elevated serum IgE levels | Significant eosinophilia (5.52 × 103/μL) and elevated serum IgE levels (19,253.00 IKU/L) were determined. Anti-Toxocara IgG antibodies were tested by ELISA and immunoblot methods.  | Serological testing for Toxocara returned positive results by both methods. | Toxocarosis was suspected after the patient was diagnosed with Pica disorder. This study highlights the importance of considering parasitosis as a cause for eosinophilia and elevated IgE levels, even in the absence of symptoms. | 
| 6 | Healy SR et al., 2024,  UK, [31]  | 266 muscle or liver samples from 155 different food-producing animals in the south, southwest and east of England | Anti-Toxocara antibodies using a commercial ELISA kit. Microscopic examination of the sample for detecting larvae.  | The overall prevalence of anti-Toxocara antibodies in tissue exudates was 27.7%. No larvae were observed microscopically in any of the samples.  | The high seroprevalence in tissue exudates suggests food animals are commonly exposed to this parasite in England and supports this testing on meat products within the human food chain in support of food safety. | 
| 7 | Bustamante J et al., 2022, Spain,  [32]  | Serum samples from 931 migrant children | IgG anti-T. canis antibodies were tested using an ELISA commercial kit (NovaLisa, NovaTec Immundiagnostica GmbH, Germany, Berlin). | 49 children (5.3%) were seropositive. | Toxocarosis is commonly asymptomatic in children, and eosinophilia is not always present. Serological tests should be included in migrant health screening and in the diagnostic assessment of eosinophilia. | 
| 8 | Balacheff Q et al., 2021, France [33]  | A clinical report of a 69-year-old Caucasian man who underwent a double lung transplantation in August 2018 for idiopathic pulmonary fibrosis | Anti-Toxocara IgG detection was carried out using an ELISA commercial assay (NovaLisa, NovaTec Immunodiagnostica GmbH, Germany) and a Western blot assay (LDBIO Diagnostics, France, Paris). | The ELISA test returned a negative result, but the Western blot test showed a typical positive profile. | The diagnosis was established based on the Western blot test result, as it had higher sensitivity and could detect a low antibody titre, due to low larval tissue presence. The authors consider that transplanted patients should be educated with a focus on the contamination through ingestion of uncooked paratenic host meat (rabbit, chicken) or interactions with the environment and the importance of hand hygiene.  | 
| 9 | Fecková M et al., 2020,  Slovakia, [34]  | Serum samples from 1489 volunteers with no symptoms of acute disease | IgG anti-Toxocara antibodies were detected by ELISA. | The overall seropositivity to Toxocara was 3.7%. The highest seropositivity rate was detected in Roma youth/children (40.3%), followed by farmers (5.5%) and hunters (5.1%), and the lowest rate, under 1%, was in veterinarians. | The results underline the importance of preventive measures and the need for improving the knowledge of toxocarosis among professionals as well as the public. | 
| 10 | Kantarakia C et al., 2020, Greece, [35]  | Questionnaire answers from 185 respondents | The objective was to assess the level of knowledge about echinococcosis and toxocarosis among cat/dog owners compared to non-pet owners. | Awareness related to the risk of Toxocara egg contamination was limited, with no difference between owners and non-owners. | The authors support the need for public health measures in the Mediterranean region regarding education about these zoonoses in order to limit their transmission. | 
| 11 | Macejova Z et al., 2020, Slovakia, [36]  | Data from a cross-sectional study that included 452 Roma and 403 non-Roma subjects from Slovakia | Anti-T. canis IgG antibodies were detected in serum samples using ELISA. | Positive serology was more common in the Roma group (22.1%) compared to the non-Roma group (1%). | The authors conclude that lower socio-economic conditions, an unhealthy lifestyle and limited access to healthcare are factors that affect the Roma population in segregated settlements and lead to an increased prevalence of some parasitic diseases. | 
| 12 | Pennelegion C et al.,  UK, [37]  | Questionnaire answers from 500 dog owners and 500 cat owners | The objective was to assess the rate of deworming in pets according to their risk of contracting and transmitting parasitic diseases. | The average number of dewormings per year was 3.1 for dogs and 3.1 for cats, below the minimum 4 recommended. | This study indicated that both felines and canines received lower than recommended dosing frequencies in order to reduce the risk for Toxocara spp. egg-shedding and to improve overall pet health. Also, pet owners should be educated to assess their pet’s risk and adhere better to deworming guidelines. | 
| 13 | Skulinova K et al., 2020, Czechia, [38]  | Serum samples from 4428 patients were tested in a national reference laboratory | The samples were tested for anti-Toxocara IgG antibodies. | 160 (3.6%) individuals included in the study were seropositive for Toxocara. | This study showed a decrease in overall Toxocara seroprevalence in the Czech population compared to data from 1998 and 2004. | 
| 14 | Magnaval JF et al., 2020, France, [39]  | 106 file records of patients diagnosed active, symptomatic, common/covert toxocarosis | The patients were divided into two groups—atopic (49) and non-atopic (57)—and serum total IgE and specific anti-Toxocara IgE were compared. | The study found no statistically significant difference in the seroprevalence of the two groups. | The authors reported that atopy did not influence the clinical or laboratory pictures of patients with toxocarosis. | 
| 15 | Strube C et al., 2020,  Germany, [40]  | 41 European publications were analysed to establish an overall Toxocara seroprevalence in Europe | A meta-analysis of the studies was performed. | The overall seroprevalence was determined to be 6.2%, and a decade-by-decade analysis from the 1970s to 2010s showed an increase from 1.6% to 12.4%. | The authors pointed out that the apparent increase in prevalence could have been due to the increase in test sensitivity and study design biases.  The research group underlined the importance of a One Health approach for toxocarosis management.  | 
| 16 | Nicoletti A et al., 2020,  Italy, [41]  | Cerebrospinal fluid (CSF) samples from 28 patients with idiopathic myelitis | Antibodies against Toxocara spp. were measured in CSF using a multiplex bead-based assay and an immunoblot assay. | All samples tested negative for the presence of anti-Toxocara IgG antibodies. | This study found no evidence of neurotoxocarosis contributing to the burden of myelitis. | 
| 17 | Brydak-Godowska J et al., 2018, Poland, [42]  | Medical records of 279 patients diagnosed with uveitis were analysed | Statistical analysis of the medical records also evaluated the aetiology of uveitis. | Toxocarosis was fond to be the cause for uveitis in 6.1% of cases, with a statistical difference between male and female patients. | This paper showed that the causes of uveitis in Europe are varied and that genetic, geographic, social and environmental factors could influence its cause in different populations. | 
| 18 | Peju M et al., 208, France, [43]  | Medical records of 298 patients with eosinophilia were analysed | Statistical analysis of the medical records evaluated the aetiology of eosinophilia. | 91 patients were tested for helminthic infections, and 3 were diagnosed with toxocarosis, all of whom did not travel to a tropical area. | Drug-related eosinophilia was found to be the principal aetiology. In eosinophilic patients who did not travel to a tropical region, the authors recommend that toxocarosis should be the only helminthosis tested as aetiology. | 
| 19 | Overbosch FW et al., 2018, the Netherlands, [44]  | Pre- and post-travel blood samples from 604 long-term travellers | IgG antibodies against Toxacara and various other parasites were tested by different commercial ELISA kits. | Antibodies against Toxocara spp. were detected in 1 patient (0.2%).  | Long-term travellers were considered to have a low risk of helminthic infections, and routine screening for eosinophilia appeared not to be of diagnostic value. | 
| 20 | Kroten A et al., 2018,  Poland [45]  | Blood samples and medical data were analysed for a cohort of 66 children with toxocarosis over 24 months | The toxocarosis diagnosis was based on specific IgG antibody detection by ELISA and Western blot. Total IgE titres were determined by IF. | School children had higher IgG titres than preschoolers, and their tier significantly decreased after treatment. Total IgE concentrations were increased in 31 of 55 (56%) tested children.  | Children at risk for toxocarosis were found to have poor hygiene habits and daily contact with dogs, and they were at risk of reinfection and limited treatment efficiency. The authors advised doctors to suspect toxocarosis, particularly in patients from areas heavily contaminated with Toxocara eggs. | 
| 21 | Boldiš V et al., 2018,  Slovakia [46]  | Serum samples from 62 patients suspected of toxocarosis | Serum samples were tested for specific IgG and IgA antibodies by ELISA, followed by an IgG avidity test. | All 52 patients were seropositive for anti-Toxocara IgG. Of these, 32.7% were also IgA seropositive, found to be highest in the oldest age groups (p = 0.026). | The authors considered that anti-Toxocara IgA can be tested to facilitate the diagnosis of toxocarosis in acute infection. This should be correlated with other immunological markers, such as increased total IgE, eosinophilia and low-avidity IgG antibodies. | 
| 22 | Jõgi NO et al., 2018, Norway, [47]  | Paired medical data and blood samples from 171 parents and 264 children | IgG anti-Toxocara antibodies were detected by ELISA. | The specific antibodies were detected in 17.5% of patients and 8.0% of offspring. | This study indicated that parental Toxocara seropositivity was associated with increased offspring allergies in a sex-specific pattern. Exposure to this helminth was more frequent in parents than children, but seropositivity was associated with increased risk of allergies in offspring but not among parents. | 
| 23 | Posová H et al., 2017, Czechia [48]  | Blood samples from 220 patients with clinically isolated syndrome (CIS) and 62 multiple sclerosis (MS) patients | Antibodies against Toxocara were measured with an ELISA method together with eosinophil count and specific antibodies against other helminths. | 21 CIS patients showed eosinophilia, but none were seropositive for Toxocara. All MS patients had normal eosinophil levels, and 1 (1.6%) MS patient had a positive serological result.  | The authors considered that Toxocara infection did not represent a potential trigger of MS and that the study indirectly confirmed that parasitic infections may be protective against autoimmune disease. | 
| 24 | Martelli G et al., 2017,  Italy, [49]  | Blood samples from a total of 930 adult immigrants were investigated for 5 neglected parasitic diseases | Individuals with a high eosinophil count were tested for Toxocara serology using an ELISA test (‘DRG Toxocara canis ELISA’, DRG Instruments GmbH, Germany). | Seroprevalence for Toxocara was found to be 9.7% (11/113). | This study emphasised that neglected tropical diseases pose a major health issue among immigrants and underlined the need for targeted public health action. | 
| 25 | Gabrielli S et al., 2017,  Serbia, [50]  | Serum samples from 40 children and 298 adults | Specific anti-Toxocara antibodies were detected by ELISA, followed by Western blot confirmation. | The overall prevalence detected by ELISA was 23.5%, and 13.0% of the examined population was confirmed to be positive by Western blot. | The authors found the sensitivity of the ELISA test to be 100%, but with a specificity of 63.8%, and recommended that all laboratories follow a two-step diagnostic approach. | 
| 26 | Halsby K et al., 2017,  UK, [51]  | Medical records of 127 patients, diagnosed positive for toxocarosis during 2000–2009, from a hospital of tropical diseases and 672 positive patients from a surveillance database | Specific antibodies were determined by ELISA only, during the period 2000–2005, followed by the introduction of Western blot confirmation since 2005. | The prevalence was high during the period 1983–1996, with an important decrease in the period 2000–2009. | The authors suggest that public health campaigns in reducing environmental contamination might have been the cause of the decrease in the number of cases. | 
| 27 | Lassen B et al., 2016,  Estonia [52]  | Serum samples from 999 adults representing general Estonian population Estonian population and its selected subgroups for serological evidence of exposure to Ascaris lumbricoides, Echinococcus spp., Taenia solium and T. canis  | IgG antibodies against T. canis and other parasites were detected by a commercial ELISA assay, followed by Western blot confirmation. | T. canis seroprevalence was 12.1%, and Toxocara spp. seroprevalence was 14.5. | Confirmed Toxocara spp. seroprevalence was found to be higher in animal caretakers than in the general population. Exposure to zoonotic parasites was found in all tested groups. The authors underline the need for higher awareness of zoonotic parasitic infections in Estonia. | 
| 28 | Mughini-Gras L et al., 2016, The Netherlands [53]  | Serum samples from 1159 individuals collected in 1995–1996 and from 3675 individuals collected in 2006–2007 | Anti-Toxocara and anti-Ascaris IgG antibodies were detected using an ELISA assay. | Toxocara seroprevalence decreased significantly from 10.7% to 8.0%, while Ascaris seroprevalence increased significantly from 30.4% to 41.6% during the 10-year period. | Differing trends in Toxocara and Ascaris seroprevalence were observed, attributed to improved pet hygiene and increased exposure to pig-manure-contaminated soil. This study suggests that these infections are mainly environmentally transmitted, with contact with contaminated soil and ownership of cats or pigs representing key modifiable risk factors. | 
| 29 | Papavasilopoulos V et al., 2016, Greece [54]  | 270 soil samples around Athens and 25 blood samples from pregnant women living in the area | Microscopy of the soil samples was performed to detect eggs. An ELISA IgG assay was used for the serum.  | The prevalence of T. canis infection in a population of Greek pregnant women was found to be at a rate of 17.16%. Soil sample positivity rate was 17.08%. | The authors suggest a correlation between the positive response in the ELISA assay IgG antibodies and the activities of people where soil was contaminated by Toxocara eggs. | 
| 30 | Boldiš V et al., 2015,  Slovakia, [55]  | Serum samples from 7678 individuals | Anti-Toxocara IgG antibodies and IgG avidity were evaluated by an ELISA assay. | The IgG anti-Toxocara seroprevalence in people from western Slovakia was found to be 15.3%, higher in the oldest age groups. Low-avidity anti-Toxocara IgG antibodies were detected in 27 cases out of 88 and were associated with eosinophilia.  | The study indicated that, besides anti-Toxocara IgG, the measurement of IgG avidity could be a useful test for acute toxocarosis and should be correlated with other determinants of examined patients, such as eosinophilia, increased total IgE and age. | 
| Author, Year, Country | Aim of the Study and Assay Used  | Results | Clinical Utility | 
|---|---|---|---|
| Serological methods | |||
| Baharudeen Z et al.,  2022, Malaysia [63]  | The authors aimed to isolate and produce novel recombinant monoclonal antibodies against T. canis recombinant TES-26 antigen (rTES-26) by utilising a human helminth scFv phage display library. | The isolated antibody clones were characterised based on their gene sequences and binding characteristics. Three clones representing unique gene families (clone 48: IgHV3-LV1; clone 49: IgHV3-LV3; clone 50: IgHV6-LV3) were isolated, but only clones 48 and 49 showed successful insertion of the full-length scFv antibody sequence after sub-cloning. The antibody clones that were isolated were analysed and described using their genetic sequences and their ability to bind to the target. Three clones, each representing distinct gene families (clone 48: IgHV3-LV1; clone 49: IgHV3-LV3; clone 50: IgHV6-LV3), but only clones 48 and 49 exhibited successful insertion of the complete scFv antibody sequence following sub-cloning.  | Both monoclonal antibodies exhibited a high level of specificity and sensitivity towards the target antigen. The ELISA assay demonstrated the diagnostic capability of the monoclonal antibodies. These proteins can also be valuable for investigating interactions between hosts and parasites as well as for therapeutic purposes. | 
| Trashin S et al.,  2021, Belgium [64]  | A time-efficient sandwich immunosensor using nanobodies (small recombinant single-domain antibodies) originating form camelid heavy chain-only antibodies to detect T. canis antigens. | This test had a high sensitivity, detecting levels as low as pg/mL by using a redox cycle consisting of a photocatalytic oxidation and electrochemical reduction steps. | The authors report that this approach surpasses assays using ordinary antibodies by a factor of at least two orders of magnitude, indicating potential for electrochemical immunoassays targeting difficult-to-detect low quantities of antigens. | 
| Morales-Yánez F et al., 2020, Belgium [65]  | Nanobody-based electrochemical magnetosensor to be used for superior detection of Toxocara excretory/secretory (TES) antigens. A bivalent biotinylated nanobody was used as a capturing agent on the surface of paramagnetic beads, precoated with streptavidin. A horseradish peroxidase marked antibody was employed for detection.  | A total of 87 samples were tested, with 33 being detected positive for the TES antigen (38%), using the electrochemical magnetosensor assay. | This nanobody-based electrochemical allows for highly sensitive quantification of TES antigens in serum and could be used for the diagnosis of active human toxocarosis. | 
| Morales-Yánez F et al., 2019, Belgium [66]  | Quantitative Toxocara excretory/secretory (TES) antigen assay, to be used for diagnosing active cases of human toxocarosis. Nanobodies, single domain antigen binding fragments originating from camelid heavy chain-only antibodies, are employed for high specificity. An electrochemical magnetosensor with an amperometric read-out is used for high sensitivity results.  | TES antigen could reliably be detected at concentrations as low as 10 pg/mL in phosphate-buffered saline and 30 pg/mL in serum. | The authors consider this method to be the most sensitive TES quantitative assay tested up to this point. It could be employed to develop point of care diagnostic systems and expanded to other conditions, where high sensitivity and specificity are required. This nanobody-based assay is especially important as it detects active infection.  | 
| Molecular methods | |||
| Zibaei M et al.,  2022, Iran [67]  | This study determined the expression levels of circulating miRNA 21 and miRNA 103a as possible biomarkers for predicting and diagnosing toxocarosis in Wistar rats infected with T. canis. Serum samples were collected from the 30 Wistar rats for 60 days after infection with 2500 T. canis eggs. Plasma samples were obtained and used for quantitative real-time PCR (qPCR) tests to measure the transcription levels of miRNA 21 and miRNA 103a.  | Anti-Toxocara IgG was found in 23.3% of the infected rats, specifically in 7 out of 30. Analysis of miRNAs 21 and 103a at the molecular level revealed that the expression levels of these miRNAs were equivalent in both the Toxocara-positive and negative sample groups, with no significant correlation. | The results of this study indicate that miRNAs 21 and 103a have significant potential as biomarkers and diagnostic tools for toxocarosis. Nevertheless, the alterations in the expression of these miRNAs were insufficient to serve as diagnostic biomarkers. | 
| Avila HG et al.,  2021, Argentina [68]  | The authors conceived a new coprological loop-mediated isothermal amplification (LAMP) assay for the simultaneous detection of T. canis and T. cati. The primer targeted a specific area of the mitochondrial cox-1 gene. The amplification conditions were assessed at different temperatures and time lengths using varied concentrations of malachite green dye. The analytical sensitivity was assessed by doing serial dilutions of genomic DNA obtained from adult worms of T. canis and T. cati as well as serial dilutions of DNA isolated from faeces using an inexpensive in-house approach.  | The LAMP assay was used on faecal samples from an area where the disease is common, being able to detect very small amounts of DNA (10–100 femtograms) and diluted DNA (10−5) retrieved from the faeces. The assay had a specificity of 100%, accurately identifying the target DNA without any false positives. | This affordable and innovative technique can be used to identify the predominant causative agents of toxocarosis in regions where the disease is prevalent. It allows for the implementation of prevention methods in low-resource settings. | 
| Azimian H et al.,  2021, Iran [69]  | By using the loop-mediated isothermal amplification (LAMP) technique, the authors aimed to estimate the molecular prevalence of Toxocara species in stray cats. Toxocara eggs were separated from 95 stool samples by a flotation method. Microscopic analysis was conducted following the separation and extraction of the supernatants. The LAMP reaction was performed utilising the internal transcribed spacer 2 (ITS2) gene primers specific to Toxocara species, along with a suitable master mix.  | Upon microscopic analysis, it was determined that 19 stool samples tested positive for Toxocara. The same 19 positive samples were likewise confirmed as positive using the LAMP technique. | Preventive measures, such as sterilising stray cats, should be implemented to control their proliferation and protect public spaces from contamination. The LAMP approach, which is both simple and extremely accurate, could distinguish between distinct Toxocara species in animals. | 
| Moura MQ et al.,  2020, Brazil [70]  | In this study, a quantitative real-time polymerase chain reaction (qPCR) method was employed to detect and measure the amount of T. canis parasites in the mouse brain. A total of 24 mice were allocated into six groups. Among these groups, five were exposed to varying doses of 1000, 500, 250, 100 and 50 T. canis larvae, while the sixth group served as an uninfected control.  | Autopsies were conducted 45 days after infection to retrieve the brain, from which two 20 mg tissue samples were used for DNA extraction and analysis. The remaining brain tissue was digested to determine the larval count using microscopy. The quantity of DNA copies was determined using the standard DNA quantification curve (E = 93.4%, R2 = 0.9655 and Y = −3.415). | The findings of this paper validate the utility of the qPCR method as a valuable means of identifying and measuring T. canis DNA in murine hosts, even in cases where the tissues of the animals harbour only a small number of parasites. This study can be helpful in developing a sensitive qPCR test for human biopsy sample analysis.  | 
| Özbakış G et al., 2019, Turkey [71]  | Molecular detection of Toxocara larvae in liver, muscle, lung and brain tissue. A group of 24 BALB/c mice were exposed to 1000 embryonated T. canis eggs. Autopsies were conducted on days 2, 4, 7 and 14 after infection. Some of the samples were treated with pepsin–HCl, while the molecular technique was employed for the remaining samples to duplicate the mitochondrial DNA adenosine triphosphate (ATP) synthase subunit-6 gene area of T. canis.  | PCR analysis had a sensitivity/accuracy of 83.3%/88.8% for liver, 87.5%/91.6% for lung and 75.0%/83.3% for the brain, forelimb and hindlimb muscle samples. | While the technique was conceived and applied for BALB/c mice tissues, it is possible that it can also be employed in other non-permissive infected hosts and materials contaminated with T. canis. | 
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.  | 
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cobzaru, R.G.; Ripa, C.V.; Ursu, R.G.; Ripa, M.R.; Damian, C.; Iancu, L.S. Toxocara Seroprevalence in Europe and Considerations for Future Research. Pathogens 2025, 14, 1117. https://doi.org/10.3390/pathogens14111117
Cobzaru RG, Ripa CV, Ursu RG, Ripa MR, Damian C, Iancu LS. Toxocara Seroprevalence in Europe and Considerations for Future Research. Pathogens. 2025; 14(11):1117. https://doi.org/10.3390/pathogens14111117
Chicago/Turabian StyleCobzaru, Roxana Gabriela, Carmen Valerica Ripa, Ramona Gabriela Ursu, Miruna Raluca Ripa, Costin Damian, and Luminita Smaranda Iancu. 2025. "Toxocara Seroprevalence in Europe and Considerations for Future Research" Pathogens 14, no. 11: 1117. https://doi.org/10.3390/pathogens14111117
APA StyleCobzaru, R. G., Ripa, C. V., Ursu, R. G., Ripa, M. R., Damian, C., & Iancu, L. S. (2025). Toxocara Seroprevalence in Europe and Considerations for Future Research. Pathogens, 14(11), 1117. https://doi.org/10.3390/pathogens14111117
        
